Today in a late-breaking presentation at ESMO - European Society for Medical Oncology 2024, we unveil new Phase 2 data in cancer cachexia, a life-threatening wasting condition with no FDA-approved treatments. Learn more about our #cachexia research: https://lnkd.in/eNS2kcB3 #Cachexia #ESMO24?
Curtis Szmania
1 周
@Pfizer I'm thrilled to see the progress being made in cancer cachexia research, a critical area that has been underserved for far too long. As someone who has witnessed the devastating impact of this condition on patients and their loved ones, I believe it's imperative that we continue to push the boundaries of innovation to find effective solutions. What do you think is the most significant hurdle we need to overcome to bring these life-changing treatments to market? #HealthTech #CancerResearch #InnovationInMedicine
Bradwell Chase
1 周
Cachexia has long lacked effective treatment options. This breakthrough could truly change the standard of care for cancer patients. Kudos to the teams at Pfizer for their dedication and innovation in addressing this critical unmet need. Looking forward to seeing the continued progress in future studies! ??
Exciting progress in a critical area of unmet need! It's inspiring to see such advancements in cancer cachexia research—looking forward to seeing the impact this could have on patient care.
Great progress in the treatment of Cachexia!. I look forward to seeing its use for those in need.
The Densu Group
1 周
Very exciting results!
Microgen Ltda
1 周
Gracias por estos nuevos e interesantes datos!
Karthikeyan SP
1 周
Great to see the new Phase 2 data on cancer cachexia being presented at ESMO 2024. It's alarming that there are currently no FDA-approved treatments for this life-threatening condition. Your research in this area is much needed and could potentially make a significant impact on the lives of those affected by cachexia. Looking forward to hearing more updates on your progress in this field. #Cachexia #ESMO24
Milen Georgiev
1 周
Wow
Cancer cachexia is a devastating condition that affects so many lives, and we're thrilled to see the progress being made towards finding effective treatments. As we navigate the complex landscape of health software, we're constantly reminded of the critical role that data plays in driving innovation and improving patient outcomes. Here are some key considerations for translating research breakthroughs into real-world solutions: a?￠ Ensuring that research is accessible and understandable to a broad audience a?￠ Developing effective collaboration models between researchers, clinicians, and industry partners a?￠ Addressing regulatory and funding barriers to accelerate the development of new treatments a?￠ Prioritizing patient-centered design and feedback to ensure that solutions meet real needs What do you think is the biggest challenge in translating research breakthroughs like this into real-world solutions that can make a tangible impact on patients' lives?